Article Details

Goldman Sachs Private Equity emerges frontrunner to acquire ChrysCap stake in GVK Biosciences

Retrieved on: 2021-04-18 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

Goldman Sachs Private Equity emerges frontrunner to acquire ChrysCap stake in GVK Biosciences. View article details on hiswai:

Excerpt

ChrysCapital entered the firm in 2015 when it picked the 10 percent stake held by Sequoia Capital. Back then, the secondary purchase valued GVK ...

Article found on: www.moneycontrol.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up